.png)
.png)
Latest news from BIA
UK biotech records third highest year for investment despite global uncertainty
New figures published today (Wednesday 22 January 2020) by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveal that the UK biotech sector raised £1.3 billion in 2019. The total is the third highest year recorded by the trade association and since 2012 investment has increased by over 400%
BIA responds to the newly announced NHS England/Novartis deal
Commenting on the new NHS England/Novartis deal and the publication of the new UK life sciences sector update announced at JP Morgan today, Steve Bates OBE, Chief Executive of the BioIndustry Association said: "Global players are announcing the UK as their destination of choice for innovation at this year’s JP Morgan Healthcare conference.
Helping BIA members to go global in 2020
The BIA will be attending a number of international conferences and events in 2020, where we will be developing closer ties with partners and promoting the strengths of the UK life sciences and biotech cluster to an international audience.
BIA reaction to the 2019 general election result
Steve Bates OBE, Chief Executive of the BIA said “A Conservative majority offers a new era of political stability at Westminster, which makes long term business decision making simpler for our sector.
Coulter Partners secures Chief Scientific Officer for OxStem
Coulter Partners was very pleased to partner once again with OxStem Limited to secure the appointment of Dr. Ian Churcher to the role of Chief Scientific Officer.
Coulter Partners secures Head of US Sales for Nanoform
Coulter Partners was delighted to partner once again with innovative nanoparticle medicine enabling company, Nanoform to secure the appointment of Sally Langa as Head of US Sales. The new role will enable Nanoform to continue its rapid growth with a strengthened presence in the US market.
NEW REPORT SHOWS IMPACT OF DISCOVERY PARK COMMUNITY LAB ON STEM EDUCATION
FUTURE PLANS TO INSPIRE MORE STUDENTS & INCREASE RANGE OF ACTIVITIES
Horizon Discovery grants a multi-product use license of its GS knockout CHO K1 cell line to NGM Bio
Cell line to be used to support research and development of biotherapeutics across therapeutic areas
CEO Update | Monday 27 January 2020
The launch of our annual finance report: ‘Global and growing: UK biotech financing in 2019’ was well received by members and the media. The report shows that the UK biotech sector is heading into the new decade in a very strong position. 2019 was the third best year recorded by the BIA and the fifth consecutive year in which more than £1bn was raised. We have seen a drop in investment globally, across all countries and sectors but it’s clear that UK biotech companies remain an attractive investment opportunity for global investors.
CEO Update|Monday 20 January
After a week of big UK announcements at JP Morgan in San Francisco, I am delighted that the positive momentum for our sector will be sustained with the release of our annual biotech financing report later this week. I look forward to celebrating the report’s findings and our sector’s successes at the premier bioscience networking event of the year, the BIA annual Gala Dinner.
CEO Update|Monday 13 January
I’m in San Francisco this week for the global healthcare event of the year – the 38th Annual JP Morgan Healthcare Conference and its associated satellite events.
Guest Blog|Artificial intelligence could help breast screening save more lives
Right now, the NHS breast cancer screening programme saves around 1,300 lives in the UK each year. But there are severe NHS staff shortages, particularly in the teams that help diagnose cancer, with some reports suggesting that up to 1 in 10 diagnostic posts are currently vacant. Throw in rising demand to the mix , and the future of these services could be in trouble.
Please find a selection of featured BIA publications below. To see our full publications library, click here.
Influencing and shaping our sector, BIA update: January - April 2018
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from January to April 2018.
Biotech Financing Update: December 2017 to February 2018
The BIA/Informa Biotech Financing Update: December 2017-February 2018 released today shows that venture capital financing and follow on financing on the public markets are off to a solid start in 2018.
Pipeline Progressing: The UK's Global Bioscience Cluster in 2017
A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.
BIA Best practice guide for communicating R&D
Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole. To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.
